Edwards Lifesciences Corp. (EW) reported first quarter EPS of $1.24 after the bell Tuesday, up from $0.55 a year ago. The consensus estimate was for EPS of $0.76. Second quarter EPS is expected to be between $0.75 and $0.79. The consensus estimate is for EPS of $0.81.
Edwards Lifesciences gapped open dramatically lower Wednesday and is now down 18.55 at $64.26 on above average volume. The stock has plunged to a new low for the year.
For comments and feedback: editorial@rttnews.com